Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations

The updated guidelines formalise recommendations for people with cirrhosis, identify other patient groups who are recommended for surveillance, and highlight gaps in evidence where the benefit of surveillance is unclear. These guidelines were accompanied by the Roadmap to liver cancer control, a coordinated ten-year plan for advancing liver cancer prevention and early detection in Australia. The full guidelines can be accessed at https://cancer.org.au/clinical-guidelines/liver-cancer/hepatocellular-carcinoma.

Authors

Institutions

Publication Details

Journal
The Medical Journal of Australia
Published
2025-09-21
DOI
https://doi.org/10.5694/mja2.70061
Citations
3
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
4.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations

Victoria Freeman, Jennifer H MacLachlan, Christopher Harrison, Catherine Holliday et al.
3 citations
The Medical Journal of Australia
Liver Disease Diagnosis and Treatment
4.06
article

Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations

Victoria Freeman, Jennifer H MacLachlan, Christopher Harrison, Catherine Holliday, Stuart Keith Roberts, Karen Canfell, Behzad Hajarizadeh, Jacob George, Nicole Allard, Denise Campbell, Anna Kelly, Rosalie Altus, Nafisa Yussf, Amanda McAtamney, Cathelijne Van Kemenade, Suzanne E. Mahady, Kate Broun, Suzanne Hughes, Eleonora Feletto, Paul Grogan, Joachim Worthington, Susan Yuill, Patricia C. Valery, Megan Varlow, Belinda Greenwood‐Smith, Leon Anton Adams, Jane Davies, Catherine Brown, Dionna M. Fry, Natali Smud, Claire Latumahina
article en
3 citations

Abstract

The updated guidelines formalise recommendations for people with cirrhosis, identify other patient groups who are recommended for surveillance, and highlight gaps in evidence where the benefit of surveillance is unclear. These guidelines were accompanied by the Roadmap to liver cancer control, a coordinated ten-year plan for advancing liver cancer prevention and early detection in Australia. The full guidelines can be accessed at https://cancer.org.au/clinical-guidelines/liver-cancer/hepatocellular-carcinoma.

The Medical Journal of AustraliaVol. 223(8)
The University of Sydney (AU), New South Wales Department of Health (AU), The University of Melbourne (AU), The University of Western Australia (AU), University of Canberra (AU), Cancer Council Victoria (AU), QIMR Berghofer Medical Research Institute (AU), The Alfred Hospital (AU), Sir Charles Gairdner Hospital (AU), Wellcome Trust Centre for the History of Medicine (GB), Flinders Medical Centre (AU), UNSW Sydney (AU), Menzies School of Health Research (AU), Peter Doherty Institute (AU), Consumer Product Testing Company (United States) (US), Alice Springs Hospital (AU), Royal Darwin Hospital (AU), Centre for Remote Health (AU), Sydney Local Health District (AU), Westmead Institute for Medical Research (AU), Hepatitis B Foundation (US), University College London (GB), Monash University (AU), Cancer Council Australia (AU), Cancer Council NSW (AU)
University of Sydney, Cancer Council NSW
Openalex Percentile: Top 6%
Liver Disease Diagnosis and Treatment
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.